<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034513483142</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034513483142</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
<subj-group subj-group-type="heading">
<subject>Clinical Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Periodontal Disease and Rheumatoid Arthritis</article-title>
<subtitle>A Systematic Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kaur</surname><given-names>S.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513483142">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>White</surname><given-names>S.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034513483142">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bartold</surname><given-names>P.M.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513483142">1</xref>
<xref ref-type="corresp" rid="corresp1-0022034513483142">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034513483142"><label>1</label>Colgate Australian Clinical Dental Research Centre (CACDRC), Adelaide Dental Hospital, University of Adelaide, SA 5005, Australia, associated with the Joanna Briggs Institute, Faculty of Health Sciences, the University of Adelaide, SA 5005</aff>
<aff id="aff2-0022034513483142"><label>2</label>The Joanna Briggs Institute, Faculty of Health Sciences, the University of Adelaide, SA 5005</aff>
<author-notes>
<corresp id="corresp1-0022034513483142"><label>*</label><email>mark.bartold@adelaide.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>92</volume>
<issue>5</issue>
<fpage>399</fpage>
<lpage>408</lpage>
<history><date date-type="received"><day>12</day>
<month>10</month>
<year>2012</year></date>
<date date-type="rev-recd"><day>23</day>
<month>1</month>
<year>2013</year></date>
<date date-type="accepted"><day>24</day>
<month>1</month>
<year>2013</year></date>
</history>
<permissions>
<copyright-statement>© 2013 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>This systematic review considers the evidence available for a relationship between periodontal disease and rheumatoid arthritis. MEDLINE/PubMed, CINAHL, DOSS, Embase, Scopus, Web of Knowledge, MedNar, and ProQuest Theses and Dissertations were searched from the inception of the database until June 2012 for any quantitative studies that examined the association between periodontal disease and rheumatoid arthritis. Nineteen studies met our inclusion criteria. Good evidence was found to support an association between these conditions with regard to tooth loss, clinical attachment levels, and erythrocyte sedimentation rates. Moderate evidence was noted for C-reactive protein and interleukin-1β. Some evidence for a positive outcome of periodontal treatment on the clinical features of rheumatoid arthritis was noted. These results provide moderate evidence based on biochemical markers and stronger evidence with regard to clinical parameters that common risk factors or common pathologic processes may be responsible for an association between rheumatoid arthritis and periodontal disease. Further studies are required to fully explore both the biochemical processes and clinical relationships between these 2 chronic inflammatory conditions. There is a need to move from case-control studies to more rigorous studies using well-defined populations and well-defined biochemical and clinical outcomes as the primary outcome measures with consideration of potential confounding factors.</p>
</abstract>
<kwd-group>
<kwd>inflammation</kwd>
<kwd>chronic disease</kwd>
<kwd>periodontics</kwd>
<kwd>rheumatology</kwd>
<kwd>biological markers</kwd>
<kwd>risk factors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034513483142">
<title>Background</title>
<p>Numerous narrative reviews have identified a possible relationship between periodontal disease and rheumatoid arthritis (<xref ref-type="bibr" rid="bibr25-0022034513483142">Mercado <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="bibr5-0022034513483142">Bartold <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr10-0022034513483142">de Pablo <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr12-0022034513483142">Detert <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr32-0022034513483142">Persson, 2012</xref>). Early studies analyzing data from self-reported illnesses, as well as more detailed case-control studies, indicated that rheumatoid arthritis patients may have a higher incidence of periodontal disease and <italic>vice versa</italic>. Further studies exploring this relationship have included investigations into cytokine profiles, inflammatory mediators, HLA-DR antigens, and hormones. Most of these studies support the notion that periodontitis and rheumatoid arthritis are inter-related and have led authors to conclude that inflammation (and its dysregulation) may be the central link between periodontitis and rheumatoid arthritis (<xref ref-type="bibr" rid="bibr5-0022034513483142">Bartold <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr10-0022034513483142">de Pablo <italic>et al</italic>., 2009</xref>). Further support for a relationship between periodontitis and rheumatoid arthritis has been highlighted in recent animal studies whereby the induction of experimental arthritis in rats resulted in an associated periodontal breakdown (<xref ref-type="bibr" rid="bibr36-0022034513483142">Ramamurthy <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr9-0022034513483142">Cantley <italic>et al</italic>., 2011</xref>).</p>
<p>From the studies to date, it is evident that periodontitis and rheumatoid arthritis have many pathologic features in common, and there may be a relationship between the extent and severity of periodontal disease and rheumatoid arthritis. While this relationship is unlikely to be causal, it appears that individuals suffering from advanced rheumatoid arthritis have more significant periodontal problems compared with their non-rheumatoid-arthritis counterparts, and <italic>vice versa</italic>. Hence, the possibility exists that both conditions result from common underlying pathologic features, resulting in a strong association between these 2 conditions. The precise nature of this “association” remains to be established.</p>
<p>The aim of this systematic review was to identify and synthesize the best available evidence regarding links between periodontal disease and rheumatoid arthritis in 4 areas: (1) to determine whether the periodontal condition of rheumatoid arthritis patients is worse than that in those without periodontal disease; (2) to assess the levels of inflammatory biomarkers in rheumatoid arthritis patients with and without periodontitis; (3) to assess the presence of periodontal bacteria in the synovium of periodontal patients with rheumatoid arthritis; and (4) to assess the effect on rheumatological clinical parameters of patients with rheumatoid arthritis and periodontal disease following periodontal treatment.</p>
<p>Before undertaking this review, we searched the Cochrane Library of Systematic Reviews, the Joanna Briggs Institute Library of Systematic Reviews, MEDLINE, and CINAHL. No systematic review was identified either as having been published or as being under way on this topic. The review was conducted in accordance with the PRISMA guidelines.</p>
</sec>
<sec id="section2-0022034513483142" sec-type="methods">
<title>Methods</title>
<sec id="section3-0022034513483142">
<title>Types of Participants</title>
<p>This review considered for inclusion studies on patients with diagnosed rheumatoid arthritis with or without a clinical diagnosis of chronic periodontitis. Participants at least 30 years of age and of both genders were considered. The lower age limit was selected to be as inclusive as possible; however, studies specifically focusing on aggressive forms of periodontitis were not considered, since the etiology and pathogenesis of this condition may be different (<xref ref-type="bibr" rid="bibr3-0022034513483142">Armitage <italic>et al</italic>., 2010</xref>). Studies where the focus was on patients with co-morbidities that may have an impact on periodontal disease and/or rheumatoid arthritis were considered to be outside the scope of this review.</p>
<p>Diagnosis of chronic periodontal disease was based on the clinical and radiographic criteria as described by the 1999 Consensus Classification of Periodontal Diseases (<xref ref-type="bibr" rid="bibr2-0022034513483142">Armitage, 1999</xref>). Diagnosis of rheumatoid arthritis was based on the clinical and biochemical features described by the American College of Rheumatology (<xref ref-type="bibr" rid="bibr4-0022034513483142">Arnett <italic>et al</italic>., 1988</xref>).</p>
</sec>
<sec id="section4-0022034513483142">
<title>Primary and Secondary Outcomes</title>
<p>This review considered studies that aimed to establish links between periodontal disease and rheumatoid arthritis. Primary rheumatoid outcome measures such as erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP), anti-citrullinated protein antibodies (Anti-CCP antibodies), and rheumatoid factor (RF) were considered. Primary periodontal outcome measures included clinical attachment loss and tooth loss. Secondary outcome measures were the presence of antibodies against <italic>Porphyromonas gingivalis</italic> and ESR levels following periodontal treatment.</p>
</sec>
<sec id="section5-0022034513483142">
<title>Types of Studies</title>
<p>This systematic review considered any quantitative studies that examined the association between periodontal disease and rheumatoid arthritis. Given the infancy of this field, it was anticipated that the majority of studies would be case-control studies and cohort prospective study designs.</p>
</sec>
<sec id="section6-0022034513483142">
<title>Search Strategy</title>
<p>The search strategy aimed to find both published and unpublished studies in the English language from inception of the database until June 2012. A three-step search strategy was utilized in this review. An initial limited search of MEDLINE and CINAHL was undertaken, followed by analysis of the text words contained in the title and abstract, and of the index terms used to describe the article. A second search using all identified key words and index terms was then undertaken across all included databases. Third, the reference list of all identified reports and articles was searched for additional studies. The databases searched for published studies included: MEDLINE/PubMed, CINAHL, DOSS, Embase, and Scopus. The search for unpublished studies included: Web of Knowledge, MedNar, and ProQuest Theses and Dissertations. Initial key words/search terms used were: rheumatoid arthritis, periodontal disease, alveolar bone loss, tooth loss, association, and risk factor. The full-strategy key words are detailed in Appendix I.</p>
</sec>
<sec id="section7-0022034513483142">
<title>Assessment of Methodological Quality</title>
<p>Prior to inclusion in the review, quantitative papers selected for retrieval were assessed for methodological validity by two independent reviewers using standardized critical appraisal instruments from the Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix II). Any disagreements that arose between the reviewers were resolved through discussion, or with a third reviewer.</p>
</sec>
<sec id="section8-0022034513483142">
<title>Data Collection</title>
<p>Quantitative data were extracted from papers included in the review by means of the standardized data extraction tool from JBI-MAStARI (Joanna Briggs Institute, University of Adelaide). The data extracted included specific details about the interventions, populations, study methods, and outcomes of significance to the review question and specific objectives.</p>
</sec>
<sec id="section9-0022034513483142">
<title>Data Synthesis</title>
<p>Quantative papers were, where possible, pooled in statistical meta-analysis with software from the Joanna Briggs Institute (JBI-MAStARI). A random-effects model and DerSimonian and Laird weighted mean difference (WMD) methods were used.</p>
</sec></sec>
<sec id="section10-0022034513483142" sec-type="results">
<title>Results</title>
<sec id="section11-0022034513483142">
<title>Description of Studies</title>
<p>The search identified 127 studies potentially relevant to the review. Based on assessment of the title and abstract, 112 studies were retrieved for examination. Of these, full texts of 61 papers were assessed for detailed examination. Thirty-two papers were excluded following full-text examination. Following retrieval, 29 articles were critically appraised for methodological quality for possible inclusion (Appendix I). Of these studies, 19 met the inclusion criteria and were included in the review (Appendix III). <xref ref-type="fig" rid="fig1-0022034513483142">Fig. 1</xref> summarizes the study identification process. Disagreement concerning 3 papers (<xref ref-type="bibr" rid="bibr11-0022034513483142">de Paula Ishi <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr14-0022034513483142">Farah Vakar <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr31-0022034513483142">Okada <italic>et al</italic>., 2011</xref>) was resolved by discussion, and those papers were subsequently included in the review.</p>
<fig id="fig1-0022034513483142" position="float">
<label>Figure 1.</label>
<caption>
<p>Joanna Briggs Institute flow diagram for studies retrieved through the searching and selection process in accordance with PRISMA guidelines.</p>
</caption>
<graphic xlink:href="10.1177_0022034513483142-fig1.tif"/></fig>
<p>All of the papers included in the review were research papers and consisted of 16 case-control and 3 experimental studies (Appendix II, <xref ref-type="table" rid="table1-0022034513483142">Table 1</xref>). They included studies published between 1989 and 2012 and were conducted across an international spectrum (<italic>i.e</italic>., India, Japan, Germany, USA, Mexico, Sweden, Norway, Turkey, and Australia), representing participants from different cultural backgrounds. A summary of the study design, clinical and laboratory data, findings, and outcomes of each included paper can be found in Appendix IV. The tests utilized by the included studies were: periodontal status of rheumatoid arthritis patients, biochemical markers in rheumatoid arthritis patients with periodontal disease, microbiological findings in rheumatoid arthritis patients with periodontal disease, and rheumatological outcomes following periodontal treatment of rheumatoid arthritis patients with periodontal disease.</p>
<table-wrap id="table1-0022034513483142" position="float">
<label>Table 1.</label>
<caption>
<p>Overall Association between Clinical Attachment Loss (CAL) and Tooth Loss Markers for Rheumatoid Arthritis (RA) and Periodontal Disease</p>
</caption>
<graphic alternate-form-of="table1-0022034513483142" xlink:href="10.1177_0022034513483142-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">CAL in RA Patients</th>
<th align="center">CAL in Non-RA Patients</th>
<th align="center">Statistical Association</th>
<th align="center">Study Design</th>
</tr>
</thead>
<tbody>
<tr>
<td><xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref></td>
<td>2.6 ± 0.05</td>
<td>3.3 ± 1.2</td>
<td><italic>p</italic> &gt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 17</td>
<td>n = 17</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr7-0022034513483142">Bozkurt <italic>et al</italic>., 2006</xref></td>
<td>4.92 ± 0.73</td>
<td>1.43 ± 0.7</td>
<td>Yes, <italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 17</td>
<td>n = 17</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr11-0022034513483142">de Paula Ishi <italic>et al</italic>., 2008</xref></td>
<td>4.4% &gt; 5.0 mm</td>
<td>2.8% &gt; 5 mm</td>
<td>Yes, <italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 39</td>
<td>n = 22</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr14-0022034513483142">Farah Vakar <italic>et al</italic>., 2010</xref></td>
<td>3.05 ± 1.02</td>
<td>2.84 ± 0.89</td>
<td>No</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 101</td>
<td>n = 101</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr16-0022034513483142">Garib and Qaradaxi, 2011</xref></td>
<td>3.24 ± 0.65</td>
<td>2.09 ± 1.09</td>
<td>Yes, <italic>p</italic> &lt; .001</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 50</td>
<td>n = 50</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr17-0022034513483142">Gleissner <italic>et al</italic>., 1998</xref></td>
<td>2.5 ± 1.8</td>
<td>1.0 ± 0.7</td>
<td>Yes, <italic>p</italic> &lt; .0001</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 100</td>
<td>n = 112</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref></td>
<td>2.88 ± 1.10</td>
<td>0.98 ± 1.04</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 100</td>
<td>n = 112</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr21-0022034513483142">Kasser <italic>et al</italic>., 1997</xref></td>
<td>2.6 ± 1.7</td>
<td>0.95 ± 0.7</td>
<td>Yes, <italic>p</italic> &lt; .0001</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 50</td>
<td>n = 50</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr31-0022034513483142">Okada <italic>et al</italic>., 2011</xref></td>
<td>3.0 ± 0.1</td>
<td>3.1 ± .01</td>
<td><italic>p</italic> = .1</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 80</td>
<td>n = 38</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref></td>
<td>4.37 ± 1.3</td>
<td>3.40 ± 0.89</td>
<td>Yes, <italic>p</italic> &lt; .001</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 57</td>
<td>n = 52</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">Missing Teeth in RA</th>
<th align="center">Missing Teeth in Non-RA</th>
<th align="center">Statistical Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr16-0022034513483142">Garib and Qaradaxi, 2011</xref></td>
<td>6.33 ± 2.7</td>
<td>3.72 ± 1.7</td>
<td><italic>p</italic> &lt; .001</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 50</td>
<td>n = 50</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr17-0022034513483142">Gleissner <italic>et al</italic>., 1998</xref></td>
<td>7.2 ± 4.4</td>
<td>5.0 ± 4.4</td>
<td><italic>p</italic> &lt; .01</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 50</td>
<td>n = 101</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref></td>
<td>5.8 ± 4.94</td>
<td>4.79 ± 4.24</td>
<td><italic>p</italic> + .259</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 100</td>
<td>n = 112</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr21-0022034513483142">Kasser <italic>et al</italic>., 1997</xref></td>
<td>7.2 ± 4.4</td>
<td>5.6 ± 4.4</td>
<td><italic>p</italic> &lt; .01</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 50</td>
<td>n = 101</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr22-0022034513483142">Kobayashi <italic>et al</italic>., 2007</xref></td>
<td>5.6 ± 0.6</td>
<td>2.3 ± 0.2</td>
<td><italic>p</italic> &lt; 0.01</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 100</td>
<td>n = 100</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr24-0022034513483142">Mercado <italic>et al</italic>., 2001</xref></td>
<td>11.6 ± 6.5</td>
<td>6.7 ± 4.2</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 65</td>
<td>n = 65</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref></td>
<td>6.58 ± 6.94</td>
<td>6.5 ± 7.10</td>
<td><italic>p</italic> = .95</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 57</td>
<td>n = 52</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section12-0022034513483142">
<title>Statistical Analyses – Clinical Studies &amp; Biochemical Markers</title>
<p>For all studies included in this review, frequency distributions, and means and standard deviations of outcome measures were determined to describe the data, and non-parametric tests were mainly used for continuous/dichotomous variables. All data were analyzed with a statistical software package. Statistical significance was declared if the <italic>p</italic> value was &lt; .05.</p>
</sec>
<sec id="section13-0022034513483142">
<title>Periodontal Status of Rheumatoid Arthritis Patients</title>
<sec id="section14-0022034513483142">
<title>Clinical Attachment Loss (CAL)</title>
<p>Ten studies investigated clinical attachment loss in rheumatoid arthritis patients with and without periodontitis (<xref ref-type="bibr" rid="bibr21-0022034513483142">Kasser <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="bibr17-0022034513483142">Gleissner <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="bibr7-0022034513483142">Bozkurt <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr11-0022034513483142">de Paula Ishi <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr14-0022034513483142">Farah Vakar <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr16-0022034513483142">Garib and Qaradaxi, 2011</xref>; <xref ref-type="bibr" rid="bibr31-0022034513483142">Okada <italic>et al</italic>., 2011</xref>; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>). All but 3 of the studies showed a statistically significant difference between CAL in non-rheumatoid arthritis patients and rheumatoid arthritis patients (<xref ref-type="table" rid="table1-0022034513483142">Table 1</xref>). When combined in meta-analysis, the overall WMD difference between the rheumatoid arthritis and non-rheumatoid arthritis groups was 1.17 (95%CI 0.43, 1.90). This suggests that clinical attachment loss is greater in patients with rheumatoid arthritis than in those without rheumatoid arthritis (<xref ref-type="fig" rid="fig2-0022034513483142">Fig. 2A</xref>).</p>
<fig id="fig2-0022034513483142" position="float">
<label>Figure 2.</label>
<caption>
<p>Forest plots showing the weighted mean difference (WMD) in <bold>(A)</bold> clinical attachment level (CAL) between rheumatoid arthritis patients and non-RA controls; <bold>(B)</bold> tooth loss between RA patients and non-RA controls; <bold>(C)</bold> erythrocyte sedimentation rate (ESR) between periodontitis-positive patients and periodontitis-negative controls; and <bold>(D)</bold> C-reactive protein (CRP) between periodontitis-positive patients and periodontitis-negative controls.</p>
</caption>
<graphic xlink:href="10.1177_0022034513483142-fig2.tif"/></fig>
</sec>
<sec id="section15-0022034513483142">
<title>Tooth Loss</title>
<p>Seven studies examined the extent of tooth loss in patients with and without rheumatoid (<xref ref-type="bibr" rid="bibr21-0022034513483142">Kasser <italic>et al</italic>., 1997</xref>; <xref ref-type="bibr" rid="bibr17-0022034513483142">Gleissner <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="bibr24-0022034513483142">Mercado <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr22-0022034513483142">Kobayashi <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr16-0022034513483142">Garib and Qaradaxi, 2011</xref>; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>). All but 2 (<xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref> &amp; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>) of the studies showed a statistically significant difference in the amount of tooth loss between non-rheumatoid arthritis patients and rheumatoid arthritis patients (<xref ref-type="table" rid="table1-0022034513483142">Table 1</xref>). When combined in meta-analysis, the overall WMD difference between the rheumatoid arthritis and non-rheumatoid arthritis groups was 2.38 (95%CI 1.48, 3.29). This indicates that increased tooth loss is associated with individuals who have rheumatoid arthritis compared with those without rheumatoid arthritis (<xref ref-type="fig" rid="fig2-0022034513483142">Fig. 2B</xref>).</p>
</sec></sec>
<sec id="section16-0022034513483142">
<title>Biochemical Markers in Rheumatoid Arthritis Patients with Periodontal Disease</title>
<sec id="section17-0022034513483142">
<title>Erythrocyte Sedimentation Rate (ESR)</title>
<p>ESR is a technique used to determine the presence of systemic inflammation and has been used as a diagnostic aid for the determination of rheumatoid arthritis (<xref ref-type="bibr" rid="bibr42-0022034513483142">Wolfe, 1997</xref>). A recent report has indicated that ESR is not affected by periodontal status (<xref ref-type="bibr" rid="bibr35-0022034513483142">Prakash <italic>et al</italic>., 2012</xref>). Four studies were included which measured ESR in patients with both rheumatoid arthritis and periodontitis (<xref ref-type="bibr" rid="bibr24-0022034513483142">Mercado <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>). Frequency distributions and means and standard deviations of ESR readings were determined to describe the data (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>). Two of the 3 included studies (<xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref> &amp; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>) showed a statistically significant difference in ESR between periodontitis-positive patients and periodontitis-negative patients, albeit in different directions. When combined in meta-analysis, the overall WMD difference between the 2 groups was not statistically different, most likely due to the large confidence intervals (WMD 10.68 -95%CI -3.56, 24.93) and small number of studies. Based on the results of these studies, caution should be used in interpretation of these results (<xref ref-type="fig" rid="fig2-0022034513483142">Fig. 2C</xref>).</p>
<table-wrap id="table2-0022034513483142" position="float">
<label>Table 2.</label>
<caption>
<p>Overall Association between ESR, CRP, CCP, RF, TNF, IL-1β, and Microbiology as Markers for Rheumatoid Arthritis and Periodontal Disease</p>
</caption>
<graphic alternate-form-of="table2-0022034513483142" xlink:href="10.1177_0022034513483142-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">ESR (Periodontal positive case,) mean ± SD, mm/hr</th>
<th align="center">ESR (Periodontal negative control) mean ± SD, mm/hr</th>
<th align="center">Statistical Association</th>
<th align="center">Study Design</th>
</tr>
</thead>
<tbody>
<tr>
<td><xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref></td>
<td>21 ± 16.5</td>
<td>17.6 ± 11.9</td>
<td><italic>p</italic> &gt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 17</td>
<td>n = 17</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref></td>
<td>46.48 ± 28.06</td>
<td>29.14 ± 29.47</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 100</td>
<td>n = 112</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr24-0022034513483142">Mercado <italic>et al</italic>., 2001</xref></td>
<td>43.92 ± 19.42</td>
<td>20.76 ± 12.21</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 65</td>
<td>n = 65</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref></td>
<td>15 (range, 8-28)</td>
<td>16 (range, 10-30)</td>
<td><italic>p</italic> = .686</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 57</td>
<td>n = 52</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">CRP (Periodontal disease positive ) mean ± SD, mg/dL</th>
<th align="center">CRP (Periodontal disease negative) mean ± SD, mg/dL</th>
<th align="center">Statistical Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref></td>
<td>0.84 ± 0.4</td>
<td>1.0 ± 1.4</td>
<td><italic>p</italic> &gt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 17</td>
<td>n = 17</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr13-0022034513483142">Dissick <italic>et al</italic>., 2010</xref></td>
<td>1.25 ± 0.55</td>
<td>Not determined</td>
<td>No correlation</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 91</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref></td>
<td>2.08 ± 3.03</td>
<td>0.30 ± .68</td>
<td>Correlation/<italic>p</italic> = .000</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 100</td>
<td>n = 112</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr24-0022034513483142">Mercado <italic>et al</italic>., 2001</xref></td>
<td>40.92 ± 19.73</td>
<td>12.03 ± 9.7</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 65</td>
<td>n = 65</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref></td>
<td>0.15 mg/dL (range, 8-28)</td>
<td>0.21 mg/dL (range, 0.09-0.64)</td>
<td><italic>p</italic> = .74</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 57</td>
<td>n = 52</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">Anti-CCP Antibodies (Periodontal disease positive)</th>
<th align="center">Anti-CCP Antibodies (Periodontal disease negative)</th>
<th align="center">Statistical Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr13-0022034513483142">Dissick <italic>et al</italic>., 2010</xref></td>
<td>87%</td>
<td>Not determined</td>
<td>No correlation</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 91</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref></td>
<td>Mean, 154.50 U/mL (range, 15.00-639.50)</td>
<td>Mean, 194 U/mL (range, 33.20-978.00)</td>
<td><italic>p</italic> = .51</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 57</td>
<td>n = 52</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">RF (Periodontal disease positive case), mean ± SD, IU/mL</th>
<th align="center">RF (Periodontal disease negative control), mean ± SD, IU/mL</th>
<th align="center">Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr13-0022034513483142">Dissick <italic>et al</italic>., 2010</xref></td>
<td>84%</td>
<td>Not determined</td>
<td>No correlation</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 91</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref></td>
<td>104 (range, 26-200)</td>
<td>70 (range, 22-444)</td>
<td><italic>p</italic> = .561</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 57</td>
<td>n = 52</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">TNF (Periodontal disease positive case), Mean ± SD, pg/mL</th>
<th align="center">TNF (Periodontal disease negative control), Mean ± SD, pg/mL</th>
<th align="center">Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr27-0022034513483142">Mirrielees <italic>et al</italic>., 2010</xref></td>
<td>11.4%</td>
<td>8.6%</td>
<td>No correlation</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 35</td>
<td>n = 35</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center">IL-1β (Periodontitis positive case), Mean ± SD, pg/mL</th>
<th align="center">IL-1β (Periodontitis negative control), Mean ± SD, pg/mL</th>
<th align="center">Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref></td>
<td>0.016 ± 0.049</td>
<td>0.003 ± 0.003</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 17</td>
<td>n = 17</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr27-0022034513483142">Mirrielees <italic>et al</italic>., 2010</xref></td>
<td>223.24 pg/mL</td>
<td>33.11 pg/mL</td>
<td><italic>p</italic> &lt; .002</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 35</td>
<td>n = 35</td>
<td/>
<td/>
</tr>
<tr>
<th align="left">Study</th>
<th align="center"><italic>P. gingivalis</italic> Antibody Response in RA Patients</th>
<th align="center"><italic>P. gingivalis</italic> Antibody Response in Non-RA Patients</th>
<th align="center">Association</th>
<th/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr26-0022034513483142">Mikuls <italic>et al</italic>., 2009</xref></td>
<td>67% positive</td>
<td>40% positive</td>
<td><italic>p</italic> &lt; .01</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 78</td>
<td>n = 40</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr28-0022034513483142">Moen <italic>et al</italic>., 2003</xref></td>
<td>9.85 ± 12.08 (IgG level)</td>
<td>7.7 ± 9.99 (IgG level)</td>
<td>Not significant</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>n = 116</td>
<td>n = 100</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr31-0022034513483142">Okada <italic>et al</italic>., 2011</xref></td>
<td>20 (IgG level)</td>
<td>10 (IgG level)</td>
<td><italic>p</italic> &lt; .05</td>
<td>Case-control</td>
</tr>
<tr>
<td/>
<td>m = 38</td>
<td>n = 38</td>
<td/>
<td/>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="section18-0022034513483142">
<title>C-reactive Protein (CRP)</title>
<p>C-reactive protein is an acute-phase protein synthesized by the liver and is elevated in serum under inflammatory conditions. It has been used as a marker of inflammation associated with rheumatoid arthritis and has also been reported to be elevated in periodontitis subjects (<xref ref-type="bibr" rid="bibr42-0022034513483142">Wolfe, 1997</xref>; <xref ref-type="bibr" rid="bibr39-0022034513483142">Slade <italic>et al</italic>., 2000</xref>). Five studies were included in which C-reactive protein was measured in patients with both rheumatoid arthritis and periodontitis (<xref ref-type="bibr" rid="bibr24-0022034513483142">Mercado <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr13-0022034513483142">Dissick <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>). Three of the 4 included studies (<xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr20-0022034513483142">Joseph <italic>et al</italic>., 2013</xref>) showed no statistically significant difference in CRP between periodontitis-positive patients and periodontitis-negative patients (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>). When combined in meta-analysis, the overall WMD difference between the 2 groups just attained statistical significance (WMD 4.20 -95%CI -1.63, 6.78). This suggests a low level of evidence that CRP levels may be elevated in patients with both rheumatoid arthritis and periodontal disease (<xref ref-type="fig" rid="fig2-0022034513483142">Fig. 2D</xref>).</p>
</sec>
<sec id="section19-0022034513483142">
<title>Anti-cyclic Citrullinated Protein Antibodies</title>
<p>Citrullination of proteins occurs under inflammatory conditions and results in the production of anti-citrullinated antibodies (ACPA). ACPA can be used as a marker of rheumatoid arthritis and are rarely present in the absence of rheumatoid arthritis (<xref ref-type="bibr" rid="bibr30-0022034513483142">Nishimura <italic>et al</italic>., 2007</xref>). Recently, citrullinated proteins and ACPA have been noted in inflamed periodontal tissues (<xref ref-type="bibr" rid="bibr19-0022034513483142">Harvey <italic>et al</italic>., 2013</xref>). Two studies investigating levels of anti-cyclic citrullinated protein (anti-CCP) antibodies in periodontal and rheumatoid arthritis patients were included in this study (<xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr13-0022034513483142">Dissick <italic>et al</italic>., 2010</xref>). One study reported anti-CCP antibody levels as a percentage, and the other reported the levels as U/mL (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>). None of the studies reported statistically significant higher levels of anti-CCP antibodies in patients with periodontal disease and rheumatoid arthritis. The results of these studies do not provide good evidence for a correlation between increased levels of anti-CCP antibodies and the presence of periodontal disease and rheumatoid arthritis.</p>
</sec>
<sec id="section20-0022034513483142">
<title>Rheumatoid Factor</title>
<p>Rheumatoid factor is a non-specific antibody used in the diagnosis of rheumatoid arthritis; however, not all individuals with rheumatoid arthritis are rheumatoid-factor-positive, with 15% of patients being seronegative for this marker (<xref ref-type="bibr" rid="bibr30-0022034513483142">Nishimura <italic>et al</italic>., 2007</xref>). Rheumatoid factor has also been reported to be elevated in individuals with periodontitis (<xref ref-type="bibr" rid="bibr40-0022034513483142">Thé and Ebersole, 1991</xref>). Two studies investigating levels of rheumatoid factor in periodontal and rheumatoid arthritis patients were included in this study (<xref ref-type="bibr" rid="bibr34-0022034513483142">Pischon <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="bibr13-0022034513483142">Dissick <italic>et al</italic>., 2010</xref>). One study reported statistically significant higher levels of RF in patients with periodontal disease and rheumatoid arthritis (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>). The results of these studies do not provide good evidence for a correlation between increased levels of RF and presence of periodontal disease and rheumatoid arthritis.</p>
</sec>
<sec id="section21-0022034513483142">
<title>Tumor Necrosis Factor (TNF)</title>
<p>Tumor necrosis factor is an inflammatory cytokine associated with many of the clinical problems associated with chronic inflammatory disorders such as rheumatoid arthritis and periodontitis. Its elevated level in rheumatoid arthritis has led to the development of anti-TNF antibodies as a therapy (<xref ref-type="bibr" rid="bibr8-0022034513483142">Brennan <italic>et al</italic>., 1989</xref>). Only one study investigating levels of tumor necrosis factor-α (TNF-α) in patients with both rheumatoid arthritis and periodontitis was included in this study (<xref ref-type="bibr" rid="bibr27-0022034513483142">Mirrielees <italic>et al</italic>., 2010</xref>). No correlation between TNF-α in rheumatoid arthritis patients with and without periodontal disease was noted (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>).</p>
</sec>
<sec id="section22-0022034513483142">
<title>Interleukin-1β (IL-1β)</title>
<p>Interleukin-1β is another inflammatory cytokine which is elevated in patients suffering from both rheumatoid arthritis and periodontitis. As for TNF, its elevated level in rheumatoid arthritis has led to the development of anti- IL-1β antibodies as a therapy (<xref ref-type="bibr" rid="bibr15-0022034513483142">Gabay and Arend, 1998</xref>). Two studies examining levels of Interleukin 1β (IL-1β) in patients with both rheumatoid arthritis and periodontitis were included in this study (<xref ref-type="bibr" rid="bibr6-0022034513483142">Biyikoğlu <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr27-0022034513483142">Mirrielees <italic>et al</italic>., 2010</xref>) were included in this study (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>). Reported levels of IL-1β were higher in patients with periodontal disease then in those without, and a statistically significant positive correlation of IL-1β level and periodontitis was reported in both studies. The results of these studies provide good evidence for a correlation between increased levels of IL-1β and the presence of periodontal disease and rheumatoid arthritis.</p>
</sec></sec>
<sec id="section23-0022034513483142">
<title>Microbiological Findings in Rheumatoid Arthritis Patients with Periodontal Disease</title>
<p>Three studies investigating periodontopathic bacteria in the sera of rheumatoid arthritis patients were included in this review (<xref ref-type="bibr" rid="bibr28-0022034513483142">Moen <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="bibr26-0022034513483142">Mikuls <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr31-0022034513483142">Okada <italic>et al</italic>., 2011</xref>). All studies examined serum antibody responses to periodontopathic bacteria including <italic>Porphyromonas gingivalis, Bacteroides forsythus, Prevotella intermedia</italic>, and <italic>Aggregatibacter actinomycetemcomitans</italic> (<xref ref-type="table" rid="table2-0022034513483142">Table 2</xref>). A statistically significant correlation was reported in 2 studies. The results of these studies provide some evidence for a correlation between increased levels of serum antibodies to <italic>P. gingivalis</italic> in patients with rheumatoid arthritis.</p>
</sec>
<sec id="section24-0022034513483142">
<title>Rheumatological Outcomes following Periodontal Treatment of Rheumatoid Arthritis Patients with Periodontal Disease</title>
<p>Three studies which examined the effect of periodontal treatment on biochemical markers for rheumatoid arthritis disease activity were included in this study (<xref ref-type="bibr" rid="bibr37-0022034513483142">Ribeiro <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr1-0022034513483142">Al-Katma <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr33-0022034513483142">Pinho <italic>et al</italic>., 2009</xref>). A statistically significant improvement in the rheumatological marker ESR was noted in the treatment groups (<xref ref-type="table" rid="table3-0022034513483142">Table 3</xref>). The results of these studies provide emerging evidence for a correlation between improved outcomes for rheumatoid arthritis patients who undergo periodontal treatment.</p>
<table-wrap id="table3-0022034513483142" position="float">
<label>Table 3.</label>
<caption>
<p>Effect of Periodontal Treatment on ESR Levels in Rheumatoid Arthritis Patients</p>
</caption>
<graphic alternate-form-of="table3-0022034513483142" xlink:href="10.1177_0022034513483142-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="center">RA + Periodontal Treatment</th>
<th align="center">RA – No Periodontal Treatment</th>
<th align="center">Statistical Association</th>
<th align="center">Study Design</th>
</tr>
</thead>
<tbody>
<tr>
<td><xref ref-type="bibr" rid="bibr1-0022034513483142">Al-Katma <italic>et al</italic>., 2007</xref></td>
<td>31.4 ± 24.3</td>
<td>42.7 ± 22</td>
<td>Yes, <italic>p</italic> &lt; .05</td>
<td>Experimental</td>
</tr>
<tr>
<td/>
<td>n = 17</td>
<td>n = 12</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr33-0022034513483142">Pinho <italic>et al</italic>., 2009</xref></td>
<td>22.4 ± 13.13</td>
<td>28.33 ± 8.47</td>
<td>Yes, <italic>p</italic> &lt; .001</td>
<td>Experimental</td>
</tr>
<tr>
<td/>
<td>n = 15</td>
<td>n = 15</td>
<td/>
<td/>
</tr>
<tr>
<td><xref ref-type="bibr" rid="bibr37-0022034513483142">Ribeiro <italic>et al</italic>., 2005</xref></td>
<td>53.8 (no SD provided)</td>
<td>75 (No SD provided)</td>
<td>Yes, <italic>p</italic> &lt; .05</td>
<td>Experimental</td>
</tr>
<tr>
<td/>
<td>n = 26</td>
<td>n = 16</td>
<td/>
<td/>
</tr>
</tbody>
</table></table-wrap>
</sec>
</sec>
<sec id="section25-0022034513483142" sec-type="discussion">
<title>Discussion</title>
<p>For this review, we identified 127 papers investigating the relationship between periodontal disease and rheumatoid arthritis. Based on 2 critical appraisal instruments, 19 papers were finally considered of appropriate quality to allow for an assessment of whether periodontal disease and rheumatoid arthritis are inter-related.</p>
<p>The diagnosis of periodontitis is largely based on results of clinical and radiographic examination investigating parameters such as plaque scores, gingival bleeding on probing, pocket depth, clinical attachment levels, tooth mobility, furcation involvement, tooth loss, and radiographic evidence of bone loss. The primary aim of this study was to determine whether the periodontal condition of rheumatoid arthritis patients is worse than that in those without periodontal disease. From the studies included in this review, we identified that rheumatoid arthritis patients have a significantly higher incidence of periodontal disease, measured by number of missing teeth and attachment levels. In light of this finding, we further investigated the evidence for specific features of both periodontitis and rheumatoid arthritis which might help explain the emerging evidence for a relationship between periodontal disease and rheumatoid arthritis.</p>
<p>Several hypotheses have been proposed to explain how periodontal disease and rheumatoid arthritis may be associated (<xref ref-type="fig" rid="fig3-0022034513483142">Fig. 3</xref>). One hypothesis, the “two-hit” model, suggests that a primary “hit” of chronic inflammation <italic>via</italic> chronic periodontitis, followed by a secondary arthritogenic “hit” to induce rheumatoid arthritis, can lead to exacerbated inflammatory responses (<xref ref-type="bibr" rid="bibr18-0022034513483142">Golub <italic>et al</italic>., 2006</xref>). These heightened responses may lead to increases in mediators of systemic inflammation in the circulation, including C-reactive protein, cytokines, prostanoids, matrix metalloproteinases, and tumor necrosis factor alpha, which may then further stimulate resident cells in the synovium and the periodontium, mediating connective tissue destruction.</p>
<fig id="fig3-0022034513483142" position="float">
<label>Figure 3.</label>
<caption>
<p>Concept of how periodontitis and rheumatoid arthritis might interact. <bold>(A)</bold> A model for how periodontal inflammation could prime an auto-immune response to citrullinated proteins prior to the development of rheumatoid arthritis; <bold>(B)</bold> a model representing how dysregulation of key inflammatory pathways could underlie both periodontitis and rheumatoid arthritis; and <bold>(C)</bold> a model demonstrating how both periodontitis and rheumatoid arthritis might exacerbate each other.</p>
</caption>
<graphic xlink:href="10.1177_0022034513483142-fig3.tif"/></fig>
<p>Another novel hypothesis has been proposed for the development of rheumatoid arthritis <italic>via</italic> the humoral response to periodontal bacteria (<xref ref-type="bibr" rid="bibr38-0022034513483142">Rosenstein <italic>et al</italic>., 2004</xref>). In this model, an autoimmune disease develops to proteins partially altered by bacterial enzymes. Central to this hypothesis is the appearance of anticyclic citrullinated peptide autoantibodies during the development of rheumatoid arthritis. The production of deimination enzymes by <italic>P. gingivalis</italic> can citrullinate proteins and induce autoantibodies allowing for a link between periodontal infection and the development of rheumatoid arthritis. Recent identification of citrullinated proteins and ACPA in inflamed periodontal tissues has led to the proposal that priming anti-CCP antibodies may be produced during the development of periodontitis. If a later event such as joint inflammation results in citrullination, then, in a primed individual, the subsequent antibody response could be very robust. This fits well with the above-mentioned two-hit model (<xref ref-type="bibr" rid="bibr18-0022034513483142">Golub <italic>et al</italic>., 2006</xref>).</p>
<p>Recent investigations into the relationship between osteoclast activation and vascular damage have also led to the hypothesis that both rheumatoid arthritis and periodontitis share common molecular pathways within the RANK/OPG/TRAIL axis, whereby a decrease in OPG leads to reduced vascular protection (<xref ref-type="bibr" rid="bibr5-0022034513483142">Bartold <italic>et al</italic>., 2005</xref>). In addition, increases in RANKL and TRAIL levels within inflamed tissues may result in not only the possible development of vascular damage but also the activation of osteoclasts and subsequent bone resorption.</p>
<p>The second aim of this study was to assess the levels of inflammatory biomarkers in rheumatoid arthritis patients with and without periodontitis. From the included studies, we identified that ESR and CRP may be elevated in patients with periodontal disease. Evidence for an association between RF levels and periodontal disease was poor. No correlation was noted between increased levels of anti-CCP antibodies and the presence of periodontal disease; however, the variability within the studies indicates that studies are required to investigate this further.</p>
<p>Investigations into cytokine profiles, inflammatory mediators, HLA-DR antigens, and hormones in periodontitis and rheumatoid arthritis patients have concluded that periodontitis and rheumatoid arthritis are inter-related and that dysregulation of the inflammatory response may be the link between periodontitis and rheumatoid arthritis (<xref ref-type="bibr" rid="bibr5-0022034513483142">Bartold <italic>et al</italic>., 2005</xref>). Rheumatoid arthritis is characterized by synovitis, where the synovial fluid is rich in pro-inflammatory cytokines (<italic>i.e</italic>., IL-1, IL-6, IL-8, IL-15, IL-17) as well as NF-Kappa β ligand (RANKL), which is also similar to pro-inflammatory cytokines associated with inflammation in periodontitis. Both TNF-α and IL-1β are of special interest in relation to a linkage between periodontitis and rheumatoid arthritis because of the ability of these inflammatory cytokines to up-regulate the production of PGE<sub>2</sub> and MMPs, resulting in osteoclastic formation and associated bone resorption. From the included studies in this review, we identified that IL-1β but not TNF-α is likely to be elevated in both periodontitis and rheumatoid arthritis patients; however, evidence for a correlation between levels of these cytokines in periodontitis patients and rheumatoid arthritis patients was weak, and studies are needed to investigate this further.</p>
<p>The third aim of this study was to assess the presence of periodontal bacteria in the synovium of periodontal patients with rheumatoid arthritis. Three studies were identified that reported elevated serum antibodies to several periodontopathic bacteria, including <italic>Porphyromonas gingivalis, Prevotella intermedia, Bacteroides forsythus</italic>, and <italic>Aggregatibacter actinomycetemcomitans.</italic> In addition, some evidence exists for the presence of RNA and DNA of these bacteria in the synovial fluid of rheumatoid arthritis patients (<xref ref-type="bibr" rid="bibr29-0022034513483142">Moen <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr23-0022034513483142">Martinez-Martinez <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="bibr43-0022034513483142">Ziebolz <italic>et al</italic>., 2011</xref>; <xref ref-type="bibr" rid="bibr41-0022034513483142">Témoin <italic>et al</italic>., 2012</xref>), but these studies were not included in this systematic review because they did not meet the inclusion criteria. From the studies included in this review, we identified that there is likely to be a correlation between the presence of periodontal pathogens such as <italic>A. actinomycetemcomitans</italic> and <italic>P. gingivalis</italic> in the serum of rheumatoid arthritis patients. Nonetheless, the precise role that periodontal pathogens might play in rheumatoid arthritis is speculative and requires considerably more investigation.</p>
<p>The final assessment carried out in this systematic review was an investigation into studies reporting on the effect of periodontal treatment on biochemical markers of rheumatoid arthritis disease activity (fourth aim). Three studies were included (<xref ref-type="bibr" rid="bibr37-0022034513483142">Ribeiro <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="bibr1-0022034513483142">Al-Katma <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr33-0022034513483142">Pinho <italic>et al</italic>., 2009</xref>), and the results from these studies indicate the potential for some beneficial effect of periodontal treatment in reducing some of the laboratory markers associated with clinical severity of rheumatoid arthritis. All of these studies had low numbers of participants, and larger studies with well-defined treatment groups need to be carried out before conclusive comment can be made on the effect of periodontal treatment on rheumatoid arthritis.</p>
<p>In this systematic review, aggressive periodontitis was not included because of the extreme nature of this condition, its relatively rare occurrence, treatment difficulties, and the low numbers of cases reported. Most of the included studies were convenience samples of generalized chronic periodontitis which were easy to recruit. Gender, age, smoking, and other confounding factors such as medications being taken for the management of rheumatoid arthritis were considered, but, for many studies, these parameters were not reported, thereby making it impossible to draw any definitive conclusion on the role of confounding factors.</p>
</sec>
<sec id="section26-0022034513483142" sec-type="conclusions">
<title>Conclusion</title>
<p>This systematic review has considered the best available evidence for an association between the clinical features of periodontal disease and biochemical markers for rheumatoid arthritis. While most of the studies were case-control and had relatively low sample sizes, potential associations between periodontal disease and rheumatoid arthritis have been identified. From this review, it is clear that there is a need for larger population-based studies to confirm this link. There is a need to move from case-control studies to more rigorous studies with well-defined populations and well-defined biochemical and clinical outcomes as the primary outcome measures, along with consideration of potential confounding factors.</p>
</sec>
</body>
<back>
<ack><p>The assistance of Mr. Mick Draper, Research Librarian, University of Adelaide is gratefully acknowledged.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure"><p>This work was funded by the <grant-sponsor>National Health &amp; Medical Research Council of Australia</grant-sponsor> (Grant number <grant-num>1023747</grant-num>).</p></fn>
<fn fn-type="conflict"><p>The authors declare no conflicts of interest with respect to the authorship and/or publication of this article.</p></fn>
<fn fn-type="supplementary-material"><p>A supplemental appendix to this article is published electronically only at <ext-link ext-link-type="uri" xlink:href="http://jdr.sagepub.com/supplemental">http://jdr.sagepub.com/supplemental</ext-link>.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Katma</surname><given-names>MK</given-names></name>
<name><surname>Bissada</surname><given-names>NF</given-names></name>
<name><surname>Bordeaux</surname><given-names>JM</given-names></name>
<name><surname>Sue</surname><given-names>J</given-names></name>
<name><surname>Askari</surname><given-names>AD</given-names></name>
</person-group> (<year>2007</year>). <article-title>Control of periodontal infection reduces the severity of active rheumatoid arthritis</article-title>. <source>J Clin Rheumatol</source> <volume>13</volume>:<fpage>134</fpage>-<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr2-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Armitage</surname><given-names>GC</given-names></name>
</person-group> (<year>1999</year>). <article-title>Development of a classification system for periodontal diseases and conditions</article-title>. <source>Ann Periodontol</source> <volume>4</volume>:<fpage>1</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr3-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Armitage</surname><given-names>GC</given-names></name>
<name><surname>Cullinan</surname><given-names>MP</given-names></name>
<name><surname>Seymour</surname><given-names>GJ</given-names></name>
</person-group> (<year>2010</year>). <article-title>Comparative biology of chronic and aggressive periodontitis: introduction</article-title>. <source>Periodontol</source> <volume>2000</volume> <fpage>53</fpage>:<fpage>7</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr4-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arnett</surname><given-names>F</given-names></name>
<name><surname>Edworthy</surname><given-names>S</given-names></name>
<name><surname>Bloch</surname><given-names>D</given-names></name>
</person-group> (<year>1988</year>). <article-title>The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis</article-title>. <source>Arthritis Rheum</source> <volume>31</volume>:<fpage>315</fpage>-<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr5-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bartold</surname><given-names>PM</given-names></name>
<name><surname>Marshall</surname><given-names>RI</given-names></name>
<name><surname>Haynes</surname><given-names>DR</given-names></name>
</person-group> (<year>2005</year>). <article-title>Periodontitis and rheumatoid arthritis: a review</article-title>. <source>J Periodontol</source> <volume>76</volume>(<supplement>11 Suppl</supplement>):<fpage>2066S</fpage>-<lpage>2074S</lpage>.</citation>
</ref>
<ref id="bibr6-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biyikoğlu</surname><given-names>B</given-names></name>
<name><surname>Buduneli</surname><given-names>N</given-names></name>
<name><surname>Kardeşler</surname><given-names>L</given-names></name>
<name><surname>Aksu</surname><given-names>K</given-names></name>
<name><surname>Oder</surname><given-names>G</given-names></name>
<name><surname>Kütükçüler</surname><given-names>N</given-names></name>
</person-group> (<year>2006</year>). <article-title>Evaluation of t-PA, PAI-2, IL-1β and PGE2 in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease</article-title>. <source>J Clin Periodontol</source> <volume>33</volume>:<fpage>605</fpage>-<lpage>611</lpage>.</citation>
</ref>
<ref id="bibr7-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bozkurt</surname><given-names>FY</given-names></name>
<name><surname>Ay</surname><given-names>ZY</given-names></name>
<name><surname>Berker</surname><given-names>E</given-names></name>
<name><surname>Tepe</surname><given-names>E</given-names></name>
<name><surname>Akkus</surname><given-names>S</given-names></name>
</person-group> (<year>2006</year>). <article-title>Anti-inflammatory cytokines in gingival crevicular fluid in patients with periodontitis and rheumatoid arthritis: a preliminary report</article-title>. <source>Cytokine</source> <volume>35</volume>:<fpage>180</fpage>-<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr8-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>FM</given-names></name>
<name><surname>Chantry</surname><given-names>D</given-names></name>
<name><surname>Jackson</surname><given-names>A</given-names></name>
<name><surname>Maini</surname><given-names>R</given-names></name>
<name><surname>Feldmann</surname><given-names>M</given-names></name>
</person-group> (<year>1989</year>). <article-title>Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis</article-title>. <source>Lancet</source> <volume>2</volume>:<fpage>244</fpage>-<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr9-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cantley</surname><given-names>MD</given-names></name>
<name><surname>Haynes</surname><given-names>DR</given-names></name>
<name><surname>Marino</surname><given-names>V</given-names></name>
<name><surname>Bartold</surname><given-names>PM</given-names></name>
</person-group> (<year>2011</year>). <article-title>Pre-existing periodontitis exacerbates experimental arthritis in a mouse model</article-title>. <source>J Clin Periodontol</source> <volume>38</volume>:<fpage>532</fpage>-<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr10-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Pablo</surname><given-names>P</given-names></name>
<name><surname>Chapple</surname><given-names>IL</given-names></name>
<name><surname>Buckley</surname><given-names>CD</given-names></name>
<name><surname>Dietrich</surname><given-names>T</given-names></name>
</person-group> (<year>2009</year>). <article-title>Periodontitis in systemic rheumatic diseases</article-title>. <source>Nat Rev Rheumatol</source> <volume>5</volume>:<fpage>218</fpage>-<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr11-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Paula Ishi</surname><given-names>E</given-names></name>
<name><surname>Bertolo</surname><given-names>MB</given-names></name>
<name><surname>Rossa</surname><given-names>C</given-names></name>
<name><surname>Kirkwood</surname><given-names>KL</given-names></name>
<name><surname>Onofre</surname><given-names>MA</given-names></name>
</person-group> (<year>2008</year>). <article-title>Periodontal condition in patients with rheumatoid arthritis</article-title>. <source>Braz Oral Res</source> <volume>22</volume>:<fpage>72</fpage>-<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr12-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Detert</surname><given-names>J</given-names></name>
<name><surname>Pischon</surname><given-names>N</given-names></name>
<name><surname>Burmester</surname><given-names>GR</given-names></name>
<name><surname>Buttgereit</surname><given-names>F</given-names></name>
</person-group> (<year>2010</year>). <article-title>The association between rheumatoid arthritis and periodontal disease</article-title>. <source>Arthritis Res Ther</source> <volume>12</volume>:<fpage>218</fpage>.</citation>
</ref>
<ref id="bibr13-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dissick</surname><given-names>A</given-names></name>
<name><surname>Redman</surname><given-names>RS</given-names></name>
<name><surname>Jones</surname><given-names>M</given-names></name>
<name><surname>Rangan</surname><given-names>BV</given-names></name>
<name><surname>Reimold</surname><given-names>A</given-names></name>
<name><surname>Griffiths</surname><given-names>GR</given-names></name>
<etal/></person-group>. (<year>2010</year>). <article-title>Association of periodontitis with rheumatoid arthritis: a pilot study</article-title>. <source>J Periodontol</source> <volume>81</volume>:<fpage>223</fpage>-<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr14-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Farah Vakar</surname><given-names>F</given-names></name>
<name><surname>Syed Afroz</surname><given-names>A</given-names></name>
<name><surname>Ather</surname><given-names>SA</given-names></name>
</person-group> (<year>2010</year>). <article-title>Evaluation of correlation between periodontitis and rheumatoid arthritis in an Indian population</article-title>. <source>J Clin Diag Res</source> <volume>4</volume>:<fpage>3654</fpage>-<lpage>3658</lpage>.</citation>
</ref>
<ref id="bibr15-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gabay</surname><given-names>C</given-names></name>
<name><surname>Arend</surname><given-names>WP</given-names></name>
</person-group> (<year>1998</year>) <article-title>Treatment of rheumatoid arthritis with IL-1 inhibitors</article-title>. <source>Springer Semin Immunopathol</source> <volume>20</volume>:<fpage>229</fpage>-<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr16-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garib</surname><given-names>BT</given-names></name>
<name><surname>Qaradaxi</surname><given-names>SS</given-names></name>
</person-group> (<year>2011</year>). <article-title>Temporomandibular joint problems and periodontal condition in rheumatoid arthritis patients in relation to their rheumatologic status</article-title>. <source>J Oral Maxillofac Surg</source> <volume>69</volume>:<fpage>2971</fpage>-<lpage>2978</lpage>.</citation>
</ref>
<ref id="bibr17-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gleissner</surname><given-names>C</given-names></name>
<name><surname>Willershausen</surname><given-names>B</given-names></name>
<name><surname>Kasser</surname><given-names>U</given-names></name>
<name><surname>Bolten</surname><given-names>WW</given-names></name>
</person-group> (<year>1998</year>). <article-title>The role of risk factors for periodontal disease in patients with rheumatoid arthritis</article-title>. <source>Eur J Med Res</source> <volume>3</volume>:<fpage>387</fpage>-<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr18-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Golub</surname><given-names>LM</given-names></name>
<name><surname>Payne</surname><given-names>JB</given-names></name>
<name><surname>Reinhardt</surname><given-names>RA</given-names></name>
<name><surname>Nieman</surname><given-names>G</given-names></name>
</person-group> (<year>2006</year>) <article-title>Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model</article-title>. <source>J Dent Res</source> <volume>85</volume>:<fpage>102</fpage>-<lpage>105</lpage>.</citation>
</ref>
<ref id="bibr19-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>GP</given-names></name>
<name><surname>Fitzsimmons</surname><given-names>TR</given-names></name>
<name><surname>Dhamarpatni</surname><given-names>AA</given-names></name>
<name><surname>Marchant</surname><given-names>C</given-names></name>
<name><surname>Haynes</surname><given-names>DR</given-names></name>
<name><surname>Bartold</surname><given-names>PM</given-names></name>
</person-group> (<year>2013</year>). <article-title>Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva</article-title>. <source>J Periodontal Res</source> <volume>48</volume>:<fpage>252</fpage>-<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr20-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Joseph</surname><given-names>R</given-names></name>
<name><surname>Rajappan</surname><given-names>S</given-names></name>
<name><surname>Nath</surname><given-names>SG</given-names></name>
<name><surname>Paul</surname><given-names>BJ</given-names></name>
</person-group> (<year>2013</year>). <article-title>Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study</article-title>. <source>Rheumatol Int</source> <volume>33</volume>:<fpage>103</fpage>-<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr21-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kasser</surname><given-names>UR</given-names></name>
<name><surname>Gleissner</surname><given-names>C</given-names></name>
<name><surname>Dehne</surname><given-names>F</given-names></name>
<name><surname>Michel</surname><given-names>A</given-names></name>
<name><surname>Willershausen-Zonnchen</surname><given-names>B</given-names></name>
<name><surname>Bolten</surname><given-names>WW</given-names></name>
</person-group> (<year>1997</year>). <article-title>Risk for periodontal disease in patients with longstanding rheumatoid arthritis</article-title>. <source>Arthritis Rheum</source> <volume>40</volume>:<fpage>2248</fpage>-<lpage>2251</lpage>.</citation>
</ref>
<ref id="bibr22-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kobayashi</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>S</given-names></name>
<name><surname>Kuroda</surname><given-names>T</given-names></name>
<name><surname>Yamamoto</surname><given-names>K</given-names></name>
<name><surname>Sugita</surname><given-names>N</given-names></name>
<name><surname>Narita</surname><given-names>I</given-names></name>
<etal/></person-group>. (<year>2007</year>). <article-title>The Interleukin-1 and Fcγ Receptor gene polymorphisms in Japanese patients with rheumatoid arthritis and periodontitis</article-title>. <source>J Periodontol</source> <volume>78</volume>:<fpage>2311</fpage>-<lpage>2318</lpage>.</citation>
</ref>
<ref id="bibr23-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martinez-Martinez</surname><given-names>RE</given-names></name>
<name><surname>Abud-Mendoza</surname><given-names>C</given-names></name>
<name><surname>Patiño-Marin</surname><given-names>N</given-names></name>
<name><surname>Rizo-Rodríguez</surname><given-names>JC</given-names></name>
<name><surname>Little</surname><given-names>JW</given-names></name>
<name><surname>Loyola-Rodríguez</surname><given-names>JP</given-names></name>
</person-group> (<year>2009</year>). <article-title>Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients</article-title>. <source>J Clin Periodontol</source> <volume>36</volume>:<fpage>1004</fpage>-<lpage>1010</lpage>.</citation>
</ref>
<ref id="bibr24-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mercado</surname><given-names>FB</given-names></name>
<name><surname>Marshall</surname><given-names>RI</given-names></name>
<name><surname>Klestov</surname><given-names>AC</given-names></name>
<name><surname>Bartold</surname><given-names>PM</given-names></name>
</person-group>. (<year>2001</year>). <article-title>Relationship between rheumatoid arthritis and periodontitis</article-title>. <source>J Periodontol</source> <volume>72</volume>: <fpage>779</fpage>-<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr25-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mercado</surname><given-names>FB</given-names></name>
<name><surname>Marshall</surname><given-names>RI</given-names></name>
<name><surname>Bartold</surname><given-names>PM</given-names></name>
</person-group> (<year>2003</year>). <article-title>Inter-relationships between rheumatoid arthritis and periodontal disease. A review</article-title>. <source>J Clin Periodontol</source> <volume>30</volume>:<fpage>761</fpage>-<lpage>772</lpage>.</citation>
</ref>
<ref id="bibr26-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mikuls</surname><given-names>TR</given-names></name>
<name><surname>Payne</surname><given-names>JB</given-names></name>
<name><surname>Reinhardt</surname><given-names>RA</given-names></name>
<name><surname>Thiele</surname><given-names>GM</given-names></name>
<name><surname>Maziarz</surname><given-names>E</given-names></name>
<name><surname>Cannella</surname><given-names>AC</given-names></name>
<etal/></person-group>. (<year>2009</year>). <article-title>Antibody response to <italic>Porphyromonas gingivalis</italic> in subjects with rheumatoid arthritis and periodontitis</article-title>. <source>Int Immunopharmacol</source> <volume>9</volume>:<fpage>38</fpage>-<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr27-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mirrielees</surname><given-names>J</given-names></name>
<name><surname>Crofford</surname><given-names>LJ</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Kryscio</surname><given-names>RJ</given-names></name>
<name><surname>Dawson</surname><given-names>DR</given-names></name>
<name><surname>Ebersole</surname><given-names>JL</given-names></name>
<etal/></person-group>. (<year>2010</year>). <article-title>Rheumatoid arthritis and salivary biomarkers of periodontal disease</article-title>. <source>J Clin Periodontol</source> <volume>37</volume>:<fpage>1068</fpage>-<lpage>1074</lpage>.</citation>
</ref>
<ref id="bibr28-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moen</surname><given-names>K</given-names></name>
<name><surname>Brun</surname><given-names>JG</given-names></name>
<name><surname>Madland</surname><given-names>TM</given-names></name>
<name><surname>Tynning</surname><given-names>T</given-names></name>
<name><surname>Jonsson</surname><given-names>R</given-names></name>
</person-group> (<year>2003</year>). <article-title>Immunoglobulin G and A antibody responses to <italic>Bacteroides forsythus</italic> and <italic>Prevotella intermedia</italic> in sera and synovial fluids of arthritis patients</article-title>. <source>Clin Diag Lab Immunol</source> <volume>10</volume>:<fpage>1043</fpage>-<lpage>1050</lpage>.</citation>
</ref>
<ref id="bibr29-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moen</surname><given-names>K</given-names></name>
<name><surname>Brun</surname><given-names>JG</given-names></name>
<name><surname>Valen</surname><given-names>M</given-names></name>
<name><surname>Skartveit</surname><given-names>L</given-names></name>
<name><surname>Eribe</surname><given-names>EK</given-names></name>
<name><surname>Olsen</surname><given-names>I</given-names></name>
<etal/></person-group>. (<year>2006</year>). <article-title>Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs</article-title>. <source>Clin Exp Rheumatol</source> <volume>24</volume>:<fpage>656</fpage>-<lpage>663</lpage>.</citation>
</ref>
<ref id="bibr30-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nishimura</surname><given-names>K</given-names></name>
<name><surname>Sugiyama</surname><given-names>D</given-names></name>
<name><surname>Kogata</surname><given-names>Y</given-names></name>
<name><surname>Tsuji</surname><given-names>G</given-names></name>
<name><surname>Nakazawa</surname><given-names>T</given-names></name>
<name><surname>Kawano</surname><given-names>S</given-names></name>
<etal/></person-group>. (<year>2007</year>). <article-title>“Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis” (PDF)</article-title>. <source>Ann Intern Med</source> <volume>146</volume>:<fpage>797</fpage>-<lpage>808</lpage>.</citation>
</ref>
<ref id="bibr31-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okada</surname><given-names>M</given-names></name>
<name><surname>Kobayashi</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>S</given-names></name>
<name><surname>Yokoyama</surname><given-names>T</given-names></name>
<name><surname>Komatsu</surname><given-names>Y</given-names></name>
<name><surname>Abe</surname><given-names>A</given-names></name>
<etal/></person-group>. (<year>2011</year>). <article-title>Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults</article-title>. <source>J Periodontol</source> <volume>82</volume>:<fpage>1433</fpage>-<lpage>1441</lpage>.</citation>
</ref>
<ref id="bibr32-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Persson</surname><given-names>GR</given-names></name>
</person-group> (<year>2012</year>). <article-title>Rheumatoid arthritis and periodontitis—inflammatory and infectious connections. Review of the literature</article-title>. <source>J Oral Microbiol</source> [Epub Feb 13, 2012].</citation>
</ref>
<ref id="bibr33-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pinho Mde</surname><given-names>N</given-names></name>
<name><surname>Oliveira</surname><given-names>RD</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
<name><surname>Voltarelli</surname><given-names>JC</given-names></name>
</person-group> (<year>2009</year>). <article-title>Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment</article-title>. <source>Braz Dent J</source> <volume>20</volume>:<fpage>355</fpage>-<lpage>364</lpage>.</citation>
</ref>
<ref id="bibr34-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pischon</surname><given-names>N</given-names></name>
<name><surname>Pischon</surname><given-names>T</given-names></name>
<name><surname>Kroger</surname><given-names>J</given-names></name>
<name><surname>Gulmez</surname><given-names>E</given-names></name>
<name><surname>Kleber</surname><given-names>BM</given-names></name>
<name><surname>Bernimoulin</surname><given-names>JP</given-names></name>
<etal/></person-group>. (<year>2008</year>). <article-title>Association among rheumatoid arthritis, oral hygiene, and periodontitis</article-title>. <source>J Periodontol</source> <volume>79</volume>:<fpage>979</fpage>-<lpage>986</lpage>.</citation>
</ref>
<ref id="bibr35-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prakash</surname><given-names>S</given-names></name>
<name><surname>Dhingra</surname><given-names>K</given-names></name>
<name><surname>Priya</surname><given-names>S</given-names></name>
</person-group> (<year>2012</year>). <article-title>Similar hematological and biochemical parameters among periodontitis and control group subjects</article-title>. <source>Eur J Dent</source> <volume>6</volume>:<fpage>287</fpage>-<lpage>294</lpage>.</citation>
</ref>
<ref id="bibr36-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ramamurthy</surname><given-names>NS</given-names></name>
<name><surname>Greenwald</surname><given-names>RA</given-names></name>
<name><surname>Celiker</surname><given-names>MY</given-names></name>
<name><surname>Shi</surname><given-names>EY</given-names></name>
</person-group> (<year>2005</year>). <article-title>Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases</article-title>. <source>J Periodontol</source> <volume>76</volume>:<fpage>229</fpage>-<lpage>233</lpage>.</citation>
</ref>
<ref id="bibr37-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ribeiro</surname><given-names>J</given-names></name>
<name><surname>Leão</surname><given-names>A</given-names></name>
<name><surname>Novaes</surname><given-names>AB</given-names></name>
</person-group> (<year>2005</year>). <article-title>Periodontal infection as a possible severity factor for rheumatoid arthritis</article-title>. <source>J Clin Periodontol</source> <volume>32</volume>:<fpage>412</fpage>-<lpage>416</lpage>.</citation>
</ref>
<ref id="bibr38-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rosenstein</surname><given-names>ED</given-names></name>
<name><surname>Greenwald</surname><given-names>RA</given-names></name>
<name><surname>Kushner</surname><given-names>LJ</given-names></name>
<name><surname>Weissmann</surname><given-names>G</given-names></name>
</person-group> (<year>2004</year>). <article-title>Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis</article-title>. <source>Inflammation</source> <volume>28</volume>:<fpage>311</fpage>-<lpage>318</lpage>.</citation>
</ref>
<ref id="bibr39-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Slade</surname><given-names>GD</given-names></name>
<name><surname>Offenbacher</surname><given-names>S</given-names></name>
<name><surname>Beck</surname><given-names>JD</given-names></name>
<name><surname>Heiss</surname><given-names>G</given-names></name>
<name><surname>Pankow</surname><given-names>JS</given-names></name>
</person-group> (<year>2000</year>). <article-title>Acute-phase inflammatory response to periodontal disease in the US population</article-title>. <source>J Dent Res</source> <volume>79</volume>:<fpage>49</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr40-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thé</surname><given-names>J</given-names></name>
<name><surname>Ebersole</surname><given-names>JL</given-names></name>
</person-group> (<year>1991</year>). <article-title>Rheumatoid factor (RF) distribution in periodontal disease</article-title>. <source>J Clin Immunol</source> <volume>11</volume>:<fpage>132</fpage>-<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr41-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Témoin</surname><given-names>S</given-names></name>
<name><surname>Chakaki</surname><given-names>A</given-names></name>
<name><surname>Askari</surname><given-names>A</given-names></name>
<name><surname>El-Halaby</surname><given-names>A</given-names></name>
<name><surname>Fitzgerald</surname><given-names>S</given-names></name>
<name><surname>Marcus</surname><given-names>RE</given-names></name>
<etal/></person-group>. (<year>2012</year>). <article-title>Identification of oral bacterial DNA in synovial fluid of patients with arthritis with native and failed prosthetic joints</article-title>. <source>J Clin Rheumatol</source> <volume>18</volume>:<fpage>117</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr42-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wolfe</surname><given-names>F</given-names></name>
</person-group> (<year>1997</year>). <article-title>Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis</article-title>. <source>J Rheumatol</source> <volume>24</volume>:<fpage>1477</fpage>-<lpage>1485</lpage>.</citation>
</ref>
<ref id="bibr43-0022034513483142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ziebolz</surname><given-names>D</given-names></name>
<name><surname>Pabel</surname><given-names>SO</given-names></name>
<name><surname>Lange</surname><given-names>K</given-names></name>
<name><surname>Krohn-Grimberghe</surname><given-names>B</given-names></name>
<name><surname>Hornecker</surname><given-names>E</given-names></name>
<name><surname>Mausberg</surname><given-names>RF</given-names></name>
</person-group> (<year>2011</year>). <article-title>Clinical periodontal and microbiologic parameters in patients with rheumatoid arthritis</article-title>. <source>J Periodontol</source> <volume>82</volume>:<fpage>1424</fpage>-<lpage>1432</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>